NCT05199389View on ClinicalTrials.gov

Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

November 15, 2023

Study Completion Date

November 10, 2028

Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
DEVICE

Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)

MLS® Laser M6 is a PBM device that allows the patients to be treated in various positions, either sitting, lying down or at a distance, without risk of contamination. Treatment times are carefully calibrated to deliver the best possible energy dose to the tissue being treated.

Trial Locations (1)

3500

Jessa Hospital, Hasselt

All Listed Sponsors
lead

Jessa Hospital

OTHER